Rentschler Biopharma Leadership Transition to Buecheler
January 26, 2026
Rentschler Biopharma names Uwe Buecheler interim CEO after von Braunmuehl's departure, ensuring continuity during strategy execution.
January 26, 2026
Rentschler Biopharma names Uwe Buecheler interim CEO after von Braunmuehl's departure, ensuring continuity during strategy execution.